Press release
Global Increase In Infertility Rates Fuels Growth Of Fertility Drug Market Driver: Leading Transformation in the Fertility Drugs Market in 2025
What Are the Projected Growth and Market Size Trends for the Fertility Drugs Market?
The market size for fertility drugs has seen significant growth in the recent past. Its size is projected to rise from $3.13 billion in 2024 to $3.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors such as escalating infertility rates, progress in reproductive healthcare, developments in assisted reproductive technologies (ART), and increased trend for late childbearing have all contributed to this upward trend in the past.
Expectations are bullish for the fertility drugs market in the coming years, with projections indicating a surge to $4.39 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 6.9%. The increase during the prediction period is due to factors such as the aging populace, lifestyle variables, assisted reproductive technologies (ART), and personalized medicine. The forecast period will be characterized by key developments in assisted reproductive technologies (ART), ovulation-inducing drugs, and hormone treatments.
What Is Driving the Growth Trajectory of the Fertility Drugs Market?
The fertility drug market expansion is fueled by a global surge in infertility rates. Infertility, defined as the inability to become pregnant even after trying for 12 consecutive months, is tackled with the extensive use of fertility drugs for both genders. The escalating infertility figures stem primarily from physical and hormonal issues, as well as environmental elements and lifestyle choices. For addressing female infertility issues, fertility drugs play a key role in regulating their ovulation cycles, thereby impacting the sales of these medications. For example, data from the Office for National Statistics, a UK-based executive wing of the UK Statistics Authority, revealed that the total fertility rate (TFR) dipped to 1.49 children per woman in 2022, down from 1.55 in 2021, specifically in February 2024. This upward trend of infertility worldwide boosts the demand for fertility drugs, leading to a booming market for these medications.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2810&type=smp
Which Leading Companies Are Shaping the Growth of the Fertility Drugs Market?
Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma
What Are the Major Trends Shaping the Fertility Drugs Market?
Key players in the fertility drugs market, such as Lupin Limited, are diligently working on the development of inventive treatments, specifically peptide-based injectable solutions, with the aim of improving reproductive health outcomes. These treatments are medication types that use either synthetic or natural peptides to control or stimulate hormonal processes, chiefly focusing on fertility and reproductive health. In the U.S, for example, an Indian pharmaceutical company, Lupin Limited, introduced a ganirelix acetate injection in February 2024. This drug is often used alongside assisted reproductive technology (ART) procedures to prevent early ovulation during controlled ovarian stimulation processes for women undertaking IVF. Ganirelix acetate, a GnRH antagonist, supports better regulation of hormone levels thus enhancing management of the ovarian stimulation process. This U.S introduction signifies Lupin's continued devotion to widening its range of products in the reproductive health market while addressing the needs of patients undergoing fertility procedures.
What Are the Key Segments of the Fertility Drugs Market?
The fertility drugs market covered in this report is segmented -
1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report
Which Region Dominates the Fertility Drugs Market?
The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
What Is Covered In The Fertility Drugs Global Market Report?
- Market Size Analysis: Analyze the Fertility Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Fertility Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Fertility Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Fertility Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2810
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
The market size for fertility drugs has seen significant growth in the recent past. Its size is projected to rise from $3.13 billion in 2024 to $3.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors such as escalating infertility rates, progress in reproductive healthcare, developments in assisted reproductive technologies (ART), and increased trend for late childbearing have all contributed to this upward trend in the past.
Expectations are bullish for the fertility drugs market in the coming years, with projections indicating a surge to $4.39 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 6.9%. The increase during the prediction period is due to factors such as the aging populace, lifestyle variables, assisted reproductive technologies (ART), and personalized medicine. The forecast period will be characterized by key developments in assisted reproductive technologies (ART), ovulation-inducing drugs, and hormone treatments.
What Is Driving the Growth Trajectory of the Fertility Drugs Market?
The fertility drug market expansion is fueled by a global surge in infertility rates. Infertility, defined as the inability to become pregnant even after trying for 12 consecutive months, is tackled with the extensive use of fertility drugs for both genders. The escalating infertility figures stem primarily from physical and hormonal issues, as well as environmental elements and lifestyle choices. For addressing female infertility issues, fertility drugs play a key role in regulating their ovulation cycles, thereby impacting the sales of these medications. For example, data from the Office for National Statistics, a UK-based executive wing of the UK Statistics Authority, revealed that the total fertility rate (TFR) dipped to 1.49 children per woman in 2022, down from 1.55 in 2021, specifically in February 2024. This upward trend of infertility worldwide boosts the demand for fertility drugs, leading to a booming market for these medications.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2810&type=smp
Which Leading Companies Are Shaping the Growth of the Fertility Drugs Market?
Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma
What Are the Major Trends Shaping the Fertility Drugs Market?
Key players in the fertility drugs market, such as Lupin Limited, are diligently working on the development of inventive treatments, specifically peptide-based injectable solutions, with the aim of improving reproductive health outcomes. These treatments are medication types that use either synthetic or natural peptides to control or stimulate hormonal processes, chiefly focusing on fertility and reproductive health. In the U.S, for example, an Indian pharmaceutical company, Lupin Limited, introduced a ganirelix acetate injection in February 2024. This drug is often used alongside assisted reproductive technology (ART) procedures to prevent early ovulation during controlled ovarian stimulation processes for women undertaking IVF. Ganirelix acetate, a GnRH antagonist, supports better regulation of hormone levels thus enhancing management of the ovarian stimulation process. This U.S introduction signifies Lupin's continued devotion to widening its range of products in the reproductive health market while addressing the needs of patients undergoing fertility procedures.
What Are the Key Segments of the Fertility Drugs Market?
The fertility drugs market covered in this report is segmented -
1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report
Which Region Dominates the Fertility Drugs Market?
The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
What Is Covered In The Fertility Drugs Global Market Report?
- Market Size Analysis: Analyze the Fertility Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Fertility Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Fertility Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Fertility Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2810
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
